Scholarlink

Background <p>Coronavirus disease 2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Angiotensin-converting enzyme 2 (ACE2) is a key player in the pathophysiology of COVID-19, as it facilitates the cellular viral entry, which in turn causes upregulation of Angiotensin II (Ang II) which correlates with the severity of infection and inflammation.</p> Objectives <p>Assessing the serum levels of Ang-II among COVID-19 patients, and correlate it with disease severity.</p> Patients and methods <p>Eighty patients of COVID- 19 and 80 healthy subjects were enrolled in this cross sectional study. COVID-19 patients was divided to 4 groups; mild, moderate, severe, and critical groups, according to WHO classification of severity of the disease .Beside clinical, laboratory (CBC, CRP, D-dimer, liver and kidney function tests) and imaging assessment, Ang II level was measured using ELISA kits.</p> Results <p>Levels of Ang-II are significantly higher in COVID-19 patients (281.82 ± 114.54 pg/dl) compared to control (72.53 ± 21.86 pg/dl), with a p-value &lt; 0.001. Significant higher levels were detected in severe and critical cases, which were 347.65 ± 37.70 and 436.06 ± 53.00, respectively, as compared to mild and moderate cases, which were 132.16 ± 27.98 and 216.44 ± 49.47 pg/dl, respectively. An ROC curve for detection of the cutoff value of Ang II level was 115.5 pg/dl with an AUC of 0.990. Moreover, a cutoff value of Ang II for determining the severe and critical cases was 300.05 pg/dl with an AUC of 1.000.</p> Conclusion <p>Ang-II may be a potential biomarker that could aid in determining the severity of cases aiming at the development of therapeutic strategies to mitigate disease severity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Correlation between serum Angiotensin II level and severity of COVID-19 disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月29日

查看全文
  • Riem M Elmessiery,
  • Haitham Abdel Basset Hashim,
  • Rokaya Abdelaziz Mohammed,
  • Ahmed Yamany Ali,
  • Laila Ahmed Rashed,
  • Heba Mahmoud Ibrahim

摘要

Background

Coronavirus disease 2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Angiotensin-converting enzyme 2 (ACE2) is a key player in the pathophysiology of COVID-19, as it facilitates the cellular viral entry, which in turn causes upregulation of Angiotensin II (Ang II) which correlates with the severity of infection and inflammation.

Objectives

Assessing the serum levels of Ang-II among COVID-19 patients, and correlate it with disease severity.

Patients and methods

Eighty patients of COVID- 19 and 80 healthy subjects were enrolled in this cross sectional study. COVID-19 patients was divided to 4 groups; mild, moderate, severe, and critical groups, according to WHO classification of severity of the disease .Beside clinical, laboratory (CBC, CRP, D-dimer, liver and kidney function tests) and imaging assessment, Ang II level was measured using ELISA kits.

Results

Levels of Ang-II are significantly higher in COVID-19 patients (281.82 ± 114.54 pg/dl) compared to control (72.53 ± 21.86 pg/dl), with a p-value < 0.001. Significant higher levels were detected in severe and critical cases, which were 347.65 ± 37.70 and 436.06 ± 53.00, respectively, as compared to mild and moderate cases, which were 132.16 ± 27.98 and 216.44 ± 49.47 pg/dl, respectively. An ROC curve for detection of the cutoff value of Ang II level was 115.5 pg/dl with an AUC of 0.990. Moreover, a cutoff value of Ang II for determining the severe and critical cases was 300.05 pg/dl with an AUC of 1.000.

Conclusion

Ang-II may be a potential biomarker that could aid in determining the severity of cases aiming at the development of therapeutic strategies to mitigate disease severity.